Market Overview

The Global Cell and Gene Therapy Manufacturing Services Market was valued at USD 9,218.8 million in 2023 and is expected to reach USD 60,833.4 million by 2031 while growing at a CAGR of 26.6% during the forecast period (2024-2031). 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global cell and gene therapy manufacturing services market growth. Cell and gene therapy manufacturing services are specialized offerings by contract manufacturing organizations (CMOs) or other providers. They assist in developing, producing, and commercializing therapies that use living cells or genetic material to treat diseases. Due to the complexity of the manufacturing process, which demands specialized expertise and facilities, many biopharmaceutical companies may lack these capabilities in-house.

The Cell and Gene Therapy Manufacturing Services market is expected to grow significantly due to the rising prevalence of genetic disorders and chronic diseases. However, challenges like high manufacturing costs and strict regulatory requirements may hinder market expansion.

Furthermore, the global cell and gene therapy manufacturing services industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Service Type Analysis

The Global Cell and Gene Therapy Manufacturing Services Market is segmented among Cell Therapy, and Gene Therapy, based on Service Type. In 2023, Cell Therapy accounted for the majority of the market share*. 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Application Analysis

The Global Cell and Gene Therapy Manufacturing Services Market is segmented among Clinical Manufacturing, and Commercial Manufacturing, based on Application. In 2023, Clinical Manufacturing accounted for the majority of the market share*. 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Cell and Gene Therapy Manufacturing Services Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031). 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Catalent Inc., Cell and Gene Therapy Catapult, Charles River Laboratories, F. Hoffmann-La Roche Ltd, Fujifilm Holdings Corporation, Lonza, Merck KGaA, Nikon CeLL innovation Co. Ltd, Oxford Biomedica PLC, and Takara Bio Inc. 

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Cell and Gene Therapy Manufacturing Services Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Cell and Gene Therapy Manufacturing Services Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Cell and Gene Therapy Manufacturing Services Market Segmentation, By Service Type

• Global Cell and Gene Therapy Manufacturing Services Market Share Analysis, By Service Type

• Global Cell and Gene Therapy Manufacturing Services Market Growth Analysis, By Service Type

• Global Cell and Gene Therapy Manufacturing Services Market Trends, By Service Type

o Cell Therapy

Ø Allogeneic

Ø Autologous

Ø Viral Vector

o Gene Therapy

Ø Non-viral Vectors

Ø Viral Vectors

6. Global Cell and Gene Therapy Manufacturing Services Market Segmentation, By Application

• Global Cell and Gene Therapy Manufacturing Services Market Share Analysis, By Application

• Global Cell and Gene Therapy Manufacturing Services Market Growth Analysis, By Application

• Global Cell and Gene Therapy Manufacturing Services Market Trends, By Application

o Clinical Manufacturing

o Commercial Manufacturing

7. Global Cell and Gene Therapy Manufacturing Services Market Segmentation, By Indication

• Global Cell and Gene Therapy Manufacturing Services Market Share Analysis, By Indication

• Global Cell and Gene Therapy Manufacturing Services Market Growth Analysis, By Indication

• Global Cell and Gene Therapy Manufacturing Services Market Trends, By Indication

o Oncology

o Cardiovascular Diseases

o Orthopedic Diseases

o Infectious Diseases

o Other Indications

8. Global Cell and Gene Therapy Manufacturing Services Market Segmentation, By End User

• Global Cell and Gene Therapy Manufacturing Services Market Share Analysis, By End User

• Global Cell and Gene Therapy Manufacturing Services Market Growth Analysis, By End User

• Global Cell and Gene Therapy Manufacturing Services Market Trends, By End User

o Pharmaceutical and Biotechnology Companies

o Academic and Research Institutes

o Other End Users

9. Global Cell and Gene Therapy Manufacturing Services Market Segmentation, By Region

• Global Cell and Gene Therapy Manufacturing Services Market Share Analysis, By Region

• Global Cell and Gene Therapy Manufacturing Services Market Growth Analysis, By Region

• Global Cell and Gene Therapy Manufacturing Services Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

10. Competitive Landscape

• Catalent Inc.*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Cell and Gene Therapy Catapult

• Charles River Laboratories

• F. Hoffmann-La Roche Ltd

• Fujifilm Holdings Corporation

• Lonza

• Merck KGaA

• Nikon CeLL innovation Co. Ltd

• Oxford Biomedica PLC

• Takara Bio Inc.

*Similar analysis will be provided for each company listed above.